La Leggia, L. 2021. Multiple Sclerosis and Nabiximols at the times of COVID-19. European Journal of Case Reports in Internal Medicine. 8, Sup 2 (Oct. 2021). DOI:https://doi.org/10.12890/2021_V8Sup2.